Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung Function

Completed

Phase 2 Results

Eligibility Criteria

Inclusion Criteria

- Abnormal pulmonary function test results;
- focal, upper limb spasticity, upper motor neuron syndrome

Exclusion Criteria

- Previous exposure to botulinum toxin of any serotype